Why Biosimilars are changing the Pharmaceutical Industry
The pharmaceutical industry shifts due to biosimilars because these products extend medical treatment access to crucial therapeutics and minimize healthcare expenses through affordable versions of high-cost biologics. The pharmaceutical industry experiences fundamental changes because U.S. Biosimilars secure multiple regulatory approvals for exact versions of approved biologic drugs which lowers healthcare expenditures globally through their inexpensive…
divyaochre
Contract Manufacturing in Biopharma Evolving Beyond COVID-19
The COVID-19 pandemic catalyzed changes to the biopharma manufacturing landscape, with agility, innovation, and resilience becoming necessary prerequisites. And digital transformation, single-use technologies, and strategic partnerships were driving contract manufacturing that soared. Demand is rebounding, but regulatory changes and automation are reshaping the industry. Welcome to the future, where the nature of demand is shifting,…
Data-Enriched Edible Pharmaceuticals (DEEP) as Patient-Tailo
Data-enriched edible pharmaceuticals (DEEP) is a novel pharmaceutical product design principle. DEEP has been proposed as a solution for personalized medicines, where each drug product, i.e., ‘every pill’, contains both the patient-tailored dose as well as information. This unique feature allows to easily identify the medicine, receive a customised information and trace the drug product…
Navigating the Landscape of Pharmacogenomics in Diagnosis
Navigating the Landscape of Pharmacogenomics in Diagnosis to Drug Delivery in Cancer Therapeutics Vikas Jhawat, Associate Professor, Department of Pharmaceutical Science, School of Medical and Allied Science, GD Goenka University Monika Gulia, Assistant Professor, Department of Pharmaceutical Science, School of Medical and Allied Science, GD Goenka University In the realm of cancer therapeutics, pharmacogenomics has emerged as…
Enhancing Drug Quality and Efficiency with Smart Manufacturi
Smart manufacturing revolutionizes pharmaceutical production by integrating automation, AI, IoT, and blockchain for enhanced drug quality, efficiency, and safety. It reduces errors, ensures regulatory compliance, and accelerates production. Despite challenges like high investment and regulatory hurdles, its future promises personalized medicine, 3D bioprinting, and autonomous factories, transforming healthcare manufacturing standards. Introduction: Smart manufacturing development leads…
Artificial Intelligence – A current and chemical sciences
Author: Ruchi Bharti, Department of Chemistry, University Institute of Sciences, Chandigarh University Chemists are increasingly employing artificial intelligence (AI) to accomplish diverse lists of tasks. Initially, the need to enhance the drug development process and lower its massive development costs and time pushed the AI or computer-based research in chemistry. In this article, we have…
- 1
- 2